An introduction to multiplicity issues in clinical trials: the what, why, when and how.
Guowei Li,Monica Taljaard,Monica Taljaard,Edwin R. van den Heuvel,Edwin R. van den Heuvel,Mitchell Levine,Mitchell Levine,Deborah J. Cook,Deborah J. Cook,George A. Wells,George A. Wells,Philip J. Devereaux,Philip J. Devereaux,Lehana Thabane,Lehana Thabane +14 more
TLDR
An introduction to multiple testing issues in clinical trials is provided, and options for carrying out multiplicity adjustments in terms of trial design factors including Population, Intervention/Comparison, Outcome, Time frame and Analysis (PICOTA).Abstract:
In clinical trials it is not uncommon to face a multiple testing problem which can have an impact on both type I and type II error rates, leading to inappropriate interpretation of trial results. Multiplicity issues may need to be considered at the design, analysis and interpretation stages of a trial. The proportion of trial reports not adequately correcting for multiple testing remains substantial. The purpose of this article is to provide an introduction to multiple testing issues in clinical trials, and to reduce confusion around the need for multiplicity adjustments. We use a tutorial, question-and-answer approach to address the key issues of why, when and how to consider multiplicity adjustments in trials. We summarize the relevant circumstances under which multiplicity adjustments ought to be considered, as well as options for carrying out multiplicity adjustments in terms of trial design factors including Population, Intervention/Comparison, Outcome, Time frame and Analysis (PICOTA). Results are presented in an easy-to-use table and flow diagrams. Confusion about multiplicity issues can be reduced or avoided by considering the potential impact of multiplicity on type I and II errors and, if necessary pre-specifying statistical approaches to either avoid or adjust for multiplicity in the trial protocol or analysis plan.read more
Citations
More filters
Journal ArticleDOI
Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study.
Chao Gao,Yue Cai,Kan Zhang,Lei Zhou,Yao Zhang,Xijing Zhang,Qi Li,Weiqin Li,Shiming Yang,Xiaoyan Zhao,Yuying Zhao,Hui Wang,Yi Liu,Zhiyong Yin,Ruining Zhang,Rutao Wang,Ming Yang,Chen Hui,William Wijns,J William McEvoy,Osama Ibrahim Ibrahim Soliman,Yoshinobu Onuma,Patrick W. Serruys,Patrick W. Serruys,Ling Tao,Fei Li +25 more
TL;DR: While hypertension and the discontinuation of antihypertensive treatment are suspected to be related to increased risk of mortality, in this retrospective observational analysis, it did not detect any harm of RAAS inhibitors in patients infected with COVID-19.
Journal ArticleDOI
Alternate Day Fasting Improves Physiological and Molecular Markers of Aging in Healthy, Non-obese Humans.
Slaven Stekovic,Sebastian J. Hofer,Norbert J. Tripolt,Miguel A. Aon,Philipp Royer,Lukas Pein,Julia T. Stadler,Julia T. Stadler,Tobias Pendl,Barbara Prietl,Jasmin Url,Sabrina Schroeder,Jelena Tadic,Tobias Eisenberg,Christoph Magnes,Michael Stumpe,Elmar Zuegner,Natalie Bordag,Regina Riedl,Albrecht Schmidt,Ewald Kolesnik,Nicolas Verheyen,Anna Springer,Tobias Madl,Frank Sinner,Frank Sinner,Rafael de Cabo,Guido Kroemer,Barbara Obermayer-Pietsch,Jörn Dengjel,Jörn Dengjel,Harald Sourij,Thomas R. Pieber,Thomas R. Pieber,Frank Madeo +34 more
TL;DR: It is shown that 4 weeks of strict alternate day fasting (ADF) improved markers of general health in healthy, middle-aged humans while causing a 37% calorie reduction on average, and supports its safety.
Journal ArticleDOI
Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial
Patrick W. Serruys,Kuniaki Takahashi,Ply Chichareon,Ply Chichareon,Norihiro Kogame,Mariusz Tomaniak,Rodrigo Modolo,Rodrigo Modolo,Chun Chin Chang,Hidenori Komiyama,Osama Ibrahim Ibrahim Soliman,Joanna J. Wykrzykowska,Robbert J. de Winter,Maurizio Ferrario,Marcello Dominici,Paweł Buszman,Leonardo Bolognese,Carlo Tumscitz,Edouard Benit,Hans-Peter Stoll,Christian W. Hamm,Philippe Gabriel Steg,Yoshinobu Onuma,Peter Jüni,Stephan Windecker,Pascal Vranckx,Antonio Colombo,Marco Valgimigli +27 more
TL;DR: Ticagrelor monotherapy following 1-month DAPT could provide a net clinical benefit for patients with complex PCI, and these findings of a post hoc analysis should be considered as hypothesis generating.
Journal ArticleDOI
Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial.
Jennie Johnstone,Maureen O. Meade,François Lauzier,John Marshall,Erick Duan,Joanna C. Dionne,Yaseen M. Arabi,Diane Heels-Ansdell,Lehana Thabane,Daphnée Lamarche,Michael G. Surette,Nicole Zytaruk,Sangeeta Mehta,Peter Dodek,Lauralyn McIntyre,Shane W. English,Bram Rochwerg,Tim Karachi,William R. Henderson,Gordon Wood,Daniel Ovakim,Margaret S. Herridge,John Granton,M. Elizabeth Wilcox,Alberto Goffi,Henry T. Stelfox,Daniel J. Niven,John Muscedere,Francois Lamontagne,Frédérick D’Aragon,Charles St-Arnaud,Ian M Ball,Dave Nagpal,Martin Girard,Pierre Aslanian,Emmanuel Charbonney,David Williamson,Wendy I. Sligl,Jan O. Friedrich,Neill K. J. Adhikari,François Marquis,Patrick Archambault,Kosar Khwaja,Arnold S. Kristof,James Kutsogiannis,Ryan Zarychanski,Bojan Paunovic,Brenda Reeve,François Lellouche,Paul Hosek,Jennifer L Y Tsang,Alexandra Binnie,Sébastien Trop,Osama Loubani,Richard I. Hall,Robert Cirone,Steve Reynolds,Paul J Lysecki,Eyal Golan,Rodrigo Cartin-Ceba,Robert W. Taylor,Deborah J. Cook,Endotracheal Colonization Trial (Prospect) Investigators +62 more
TL;DR: In this paper, the authors evaluated the effect of L rhamnosus GG on preventing VAP, additional infections, and other clinically important outcomes in the intensive care unit (ICU).
Journal ArticleDOI
Impact of Peri-Procedural Myocardial Infarction on Outcomes After Revascularization.
Hironori Hara,Patrick W. Serruys,Patrick W. Serruys,Kuniaki Takahashi,Hideyuki Kawashima,Masafumi Ono,Chao Gao,Rutao Wang,Friedrich W. Mohr,David R. Holmes,Piroze M. Davierwala,Stuart J. Head,Daniel J F M Thuijs,Milan Milojevic,Arie Pieter Kappetein,Scot Garg,Yoshinobu Onuma,Michael J. Mack,Syntax Extended Survival Investigators +18 more
TL;DR: The PMI rates according to various definitions, their clinically relevant association with all-cause mortality at 10 years, and their impact on composite endpoints at 5 years were investigated in the SYNTAXES (Synergy between PCI with Taxus and Cardiac Surgery Extended Survival) trial.
References
More filters
Journal ArticleDOI
A Simple Sequentially Rejective Multiple Test Procedure
TL;DR: In this paper, a simple and widely accepted multiple test procedure of the sequentially rejective type is presented, i.e. hypotheses are rejected one at a time until no further rejections can be done.
Book
Practical statistics for medical research
TL;DR: Practical Statistics for Medical Research is a problem-based text for medical researchers, medical students, and others in the medical arena who need to use statistics but have no specialized mathematics background.
Journal ArticleDOI
Effects of an angiotensin-converting -enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
TL;DR: Ramipril significantly reduces the rates of death, myocardial infarction, and stroke in a broad range of high-risk patients who are not known to have a low ejection fraction or heart failure.
Journal ArticleDOI
What's wrong with Bonferroni adjustments
TL;DR: This paper advances the view, widely held by epidemiologists, that Bonferroni adjustments are, at best, unnecessary and, at worst, deleterious to sound statistical inference.
Related Papers (5)
2018 ESC/EACTS Guidelines on myocardial revascularization.
Miguel Sousa-Uva,Franz-Josef Neumann,Anders Ahlsson,Fernando Alfonso,Adrian P. Banning,Umberto Benedetto,Robert A. Byrne,Jean-Philippe Collet,Falk,Stuart J. Head,Peter Jüni,Adnan Kastrati,Akos Koller,Steen Dalby Kristensen,Josef Niebauer,Dimitrios J. Richter,Petar M. Seferovic,Dirk Sibbing,Giulio G. Stefanini,Stephan Windecker,Rashmi Yadav,Michael O. Zembala +21 more